INKT

MiNK Therapeutics (INKT)

About MiNK Therapeutics (INKT)

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.

Details

Daily high
$9.50
Daily low
$9.50
Price at open
$9.68
52 Week High
$19.00
52 Week Low
$4.56
Market cap
39.4M
Dividend yield
0.00%
Volume
3
Avg. volume
75,515
P/E ratio
-2.57

MiNK Therapeutics News

Details

Daily high
$9.50
Daily low
$9.50
Price at open
$9.68
52 Week High
$19.00
52 Week Low
$4.56
Market cap
39.4M
Dividend yield
0.00%
Volume
3
Avg. volume
75,515
P/E ratio
-2.57